Znomics Launches Obesity Drug-Discovery Program Based on OHSU Z-Fish Gene Model | GenomeWeb
Znomics this week launched a drug-discovery program designed to screen potential drug candidates using a proprietary genetic model of obesity in the zebrafish, a company official told CBA News.
The company licensed the obesity model from Oregon Health & Sciences University about a month ago and plans to further develop it so that it is applicable to drug discovery, said Stephane Berghmans, director of drug discovery at Znomics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.